However, the World Health Organization (WHO) estimates that in some developing lands, only 5 percent of those who need ARV therapy have access to the drugs.
Taču Pasaules Veselības organizācija (PVO) lēš, ka dažās attīstības valstīs tikai 5 procentiem cilvēku, kam šī terapija nepieciešama, ir pieejami ARV medikamenti.